SEC Form 4 insider trading filings tracked in real time from EDGAR

Cue Biopharma, Inc. (CUE) — Insider Trading

Insider trading activity for Cue Biopharma, Inc. sourced from SEC EDGAR Form 4 filings.

Overview

  • Total insider trades: 10
  • Last trade date: Aug 17, 2026
  • Ticker: CUE

Top Insiders

  • Lin Shao-Lee (Chief Executive Officer) — 4 trades, buy: $0, sell: $1.1M
  • Ray Sumita (Chief Legal Compliance Officer) — 3 trades, buy: $0, sell: $70K
  • Meluzio Michael Vincent (VP, Prin. Accounting Officer) — 3 trades, buy: $0, sell: $45K

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Aug 13, 2026 Ray Sumita CUE Cue Biopharma, Inc. OTHER 18,196 N/A
Aug 13, 2026 Ray Sumita CUE Cue Biopharma, Inc. SELL 2,383 $70K
Aug 13, 2026 Ray Sumita CUE Cue Biopharma, Inc. OTHER 18,196 N/A
Aug 13, 2026 Meluzio Michael Vincent CUE Cue Biopharma, Inc. OTHER 13,647 N/A
Aug 13, 2026 Meluzio Michael Vincent CUE Cue Biopharma, Inc. SELL 1,519 $45K
Aug 13, 2026 Meluzio Michael Vincent CUE Cue Biopharma, Inc. OTHER 13,647 N/A
Aug 12, 2026 Lin Shao-Lee CUE Cue Biopharma, Inc. OTHER 109,179 N/A
Aug 13, 2026 Lin Shao-Lee CUE Cue Biopharma, Inc. SELL 5,423 $147K
Aug 12, 2026 Lin Shao-Lee CUE Cue Biopharma, Inc. SELL 34,225 $924K
Aug 12, 2026 Lin Shao-Lee CUE Cue Biopharma, Inc. OTHER 109,179 N/A

← All companies · Full trades feed